DeepMed Research

Oregon Health and Science University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Phase 2

Withdrawn

Conditions: Parkinson's Disease

Interventions: Drug: Apomorphine

First Posted Date: 2008-09-25

Last Posted Date: 2018-11-02

Lead Sponsor: Oregon Health and Science University

Registration Number: NCT00758368

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

American Ginseng Treatment for Multiple Sclerosis Related Fatigue

Phase 2

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: American ginseng extract HT-1001
Drug: placebo

First Posted Date: 2008-09-18

Last Posted Date: 2012-01-24

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 56

Registration Number: NCT00754832

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Study of Ultrasound of the Eye for Children With Suspected Shunt Failure

Completed

Conditions: Hydrocephalus

Interventions: Device: Ocular Ultrasound

First Posted Date: 2008-08-28

Last Posted Date: 2012-10-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 36

Registration Number: NCT00743457

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

Phase 4

Conditions: HDL Cholesterol

Interventions: Drug: Simvastatin
Drug: Atorvastatin 80 mg

First Posted Date: 2008-08-15

Last Posted Date: 2011-07-22

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 80

Registration Number: NCT00736463

Locations: 🇺🇸
OHSU Hospital, Portland, Oregon, United States

Hood to Coast Injury Study

Phase 4

Completed

Conditions: Pain

Interventions: Dietary Supplement: Tart Cherry Juice
Dietary Supplement: Fruit juice

First Posted Date: 2008-08-13

Last Posted Date: 2019-06-20

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 65

Registration Number: NCT00733395

Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.

Not Applicable

Withdrawn

Conditions: Metabolic Syndrome

Interventions: Drug: Norditropin

First Posted Date: 2008-07-23

Last Posted Date: 2013-02-20

Lead Sponsor: Oregon Health and Science University

Registration Number: NCT00720616

Locations: 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States

A Motivational Enhancement Approach to Skin Cancer Prevention

Not Applicable

Completed

Conditions: Ultraviolet Rays
Motivation

Interventions: Behavioral: Brief Motivational Enhancement Intervention

First Posted Date: 2008-06-27

Last Posted Date: 2008-06-27

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 82

Registration Number: NCT00705887

Locations: 🇺🇸
Central Utah Clinic, Dermatology, Provo, Utah, United States

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: placebo
Drug: pioglitazone
Drug: metformin

First Posted Date: 2008-06-10

Last Posted Date: 2019-09-09

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 37

Registration Number: NCT00694759

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin

Not Applicable

Completed

Conditions: Obesity

Interventions: Dietary Supplement: Low fat diet
Dietary Supplement: High fat diet
Dietary Supplement: MCT diet

First Posted Date: 2008-06-10

Last Posted Date: 2012-05-15

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 51

Registration Number: NCT00694512

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Regulation of Cortisol Metabolism and Fat Patterning

Not Applicable

Active, not recruiting

Conditions: Obesity
Menopausal Syndrome

Interventions: Drug: Placebo injection
Drug: Estrogen cream
Drug: Depo Lupron/placebo
Drug: placebo
Drug: Depo Lupron/Aromatase inhibitor

First Posted Date: 2008-06-10

Last Posted Date: 2022-12-16

Lead Sponsor: Oregon Health and Science University

Target Recruit Count: 140

Registration Number: NCT00694733

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy